Therapy News and Research

RSS

Octapharma extends support for COVID-19 study following promising preliminary data

Following positive preliminary data, Octapharma USA is extending funding for an investigator-initiated study (IIS) focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation.

3 Jun 2020

Researchers deconstruct the mechanisms that control wound healing

ETH researchers have deconstructed the mechanisms that control wound healing and scar formation in more detail.

3 Jun 2020

Cognitive behavior therapy superior to other psychotherapies at boosting the immune system

A review of 56 randomized clinical trials finds that psychological and behavioral therapies may be effective non-drug treatments for reducing disease-causing inflammation in the body.

3 Jun 2020

New guidelines improve outcomes in colon cancer patients

A new University of Kentucky Markey Cancer Center study finds that many Kentucky patients with colon cancer are not receiving the recommended standard of care therapy for their disease.

3 Jun 2020

New test identifies CAD-affected children who may benefit from uridine

Scientists at Sanford Burnham Prebys Medical Discovery Institute and the Centro de Biología Molecular Severo Ochoa in Spain have created a test that determines which children with CAD deficiency - a rare metabolic disease - are likely to benefit from receiving uridine, a nutritional supplement that has dramatically improved the lives of other children with the condition.

3 Jun 2020

Silent hypoxia and its role in COVID-19 detection

News-Medical speaks to Dr. Albert Rizzo about silent hypoxia and how it is occurring in individuals that are suffering from COVID-19.

3 Jun 2020

Convalescent plasma therapy improves outcomes in majority of COVID-19 patients

First peer-reviewed publication on US trial results from Houston Methodist published in The American Journal of Pathology

3 Jun 2020

Mini tumors predict how cancer responds to heat treatment

Hyperthermia has shown promise in the treatment of cancer in previous studies. Now, in a new study by scientists at The Institute of Cancer Research, London, the researchers tested the effects of a combination of heat and radiation on mini tumors grown in a spheroid, where cells are placed in a three-dimensional structure. The research is published in the journal Scientific Reports.

3 Jun 2020

Early diagnosis of pulmonary embolism could enhance treatment in COVID-19 patients

Researchers at Henry Ford Health System in Detroit say early diagnosis of a life-threatening blood clot in the lungs led to swifter treatment intervention in COVID-19 patients.

2 Jun 2020

New advance addresses a big challenge with using CRISPR in cancer patients

A mutation unique to certain cancer tumors is a potential homing beacon for safely deploying CRISPR gene editing enzymes to disarm DNA that makes cancer cells resistant to treatment, while ignoring the gene in normal cells where it's critical to healthy function, according to a new study from ChristianaCare's Gene Editing Institute in the journal Molecular Cancer Research.

2 Jun 2020

Researchers test aluminum oxide crystal as a UV radiation sensor

Exposure to ultraviolet (UV) radiation is a risk factor for skin cancer and other diseases. The risk increases when sunlight, the natural source of UV radiation, is combined with artificial sources such as UV lamps for medical therapy, among others.

2 Jun 2020

Polygenic risk scores may improve clinical assessment of patients with elevated heart attack risk

Genetic variants have been linked with a higher risk of having a heart attack, permitting the calculation of "polygenic risk scores" (PRS) that quantify patients' inherited susceptibility based on the number of variants they have.

2 Jun 2020

CSL Behring and Seattle Children's partner to develop gene therapies for primary immunodeficiency diseases

Seattle Children's Research Institute, one of the top pediatric research institutions in the world, and global biotechnology leader CSL Behring announced a strategic alliance to develop stem cell gene therapies for primary immunodeficiency diseases.

2 Jun 2020

Microperimetry can help determine the efficacy of novel treatments for macular diseases

Stargardt disease is an inherited eye disease. Its onset is typically in adolescence and it is among the leading causes of blindness in this age group. Symptoms range from severe loss of sharp vision to almost complete loss of sight.

2 Jun 2020

International research consortium launched to improve obesity treatment

University College Dublin (UCD) is leading SOPHIA (Stratification of Obese Phenotypes to Optimize Future Obesity Therapy), a new €16 million EU and industry supported international research consortium launched today.

2 Jun 2020

Fraunhofer researchers investigate the mechanisms of metastasis formation

What makes tumor cells turn murderous? The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is investigating the mechanisms of metastasis formation - and searching for approaches for new treatments in the fight against cancer.

2 Jun 2020

Does interferon therapy work in COVID-19?

A new study published on the preprint site medRxiv in May 2020 reports on the efficacy of interferons in treating COVID-19. The research could help evaluate the place of such therapy in the management of this disease.

2 Jun 2020

Researchers identify key protein required for optimal immune responses to cancer

A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Solove Research Institute (OSUCCC - James) has identified a protein within certain immune cells that is required for optimal immune responses to cancer.

2 Jun 2020

A cytokine pattern that predicts adverse outcomes in COVID-19

A new study published on the preprint server medRxiv in May 2020 reports the discovery of a predictive pattern of cytokines in COVID-19 infection that could guide clinical management if validated.

2 Jun 2020

Blood test may predict a patient’s response to prostate cancer treatment

A team of researchers at The Institute of Cancer Research (ICR) in London found that the test can detect traces of cancer DNA in the bloodstream. The liquid biopsy could also identify the patients who are more likely to relapse.

1 Jun 2020